Han Zhong Pei

644 total citations
19 papers, 509 citations indexed

About

Han Zhong Pei is a scholar working on Molecular Biology, Ophthalmology and Hematology. According to data from OpenAlex, Han Zhong Pei has authored 19 papers receiving a total of 509 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 5 papers in Ophthalmology and 5 papers in Hematology. Recurrent topics in Han Zhong Pei's work include Retinal Diseases and Treatments (5 papers), Acute Myeloid Leukemia Research (4 papers) and Retinal Development and Disorders (4 papers). Han Zhong Pei is often cited by papers focused on Retinal Diseases and Treatments (5 papers), Acute Myeloid Leukemia Research (4 papers) and Retinal Development and Disorders (4 papers). Han Zhong Pei collaborates with scholars based in China, South Korea and United States. Han Zhong Pei's co-authors include Weikun Hu, Xing Wan, Suk‐Hwan Baek, Shuo Yang, Bin Huang, Xiaoyan Dong, Dao Wen Wang, Heng He, Siqi Ma and Chen Chen and has published in prestigious journals such as Blood, Scientific Reports and Ophthalmology.

In The Last Decade

Han Zhong Pei

19 papers receiving 498 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Han Zhong Pei China 12 412 123 67 61 59 19 509
Mandy K. Losiewicz United States 9 308 0.7× 141 1.1× 63 0.9× 9 0.1× 36 0.6× 11 468
Ingvild Aukrust Norway 16 464 1.1× 31 0.3× 77 1.1× 70 1.1× 15 0.3× 41 709
Dalila Bevilacqua United Kingdom 8 300 0.7× 83 0.7× 81 1.2× 93 1.5× 6 0.1× 8 433
Virginie G. Peter Switzerland 10 198 0.5× 65 0.5× 41 0.6× 19 0.3× 18 0.3× 17 325
Jennifer L. Peotter United States 9 150 0.4× 70 0.6× 137 2.0× 30 0.5× 6 0.1× 9 297
Fei-Feng Li China 14 256 0.6× 33 0.3× 15 0.2× 21 0.3× 9 0.2× 29 377
Carsten Schmelter Germany 11 187 0.5× 159 1.3× 30 0.4× 14 0.2× 15 0.3× 23 396
Diane E. Borst United States 12 311 0.8× 117 1.0× 45 0.7× 49 0.8× 3 0.1× 22 426
Andreas Janßen Germany 9 434 1.1× 452 3.7× 34 0.5× 46 0.8× 11 0.2× 10 702
Katarina Cisarova Switzerland 8 218 0.5× 136 1.1× 35 0.5× 17 0.3× 6 0.1× 12 427

Countries citing papers authored by Han Zhong Pei

Since Specialization
Citations

This map shows the geographic impact of Han Zhong Pei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Han Zhong Pei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Han Zhong Pei more than expected).

Fields of papers citing papers by Han Zhong Pei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Han Zhong Pei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Han Zhong Pei. The network helps show where Han Zhong Pei may publish in the future.

Co-authorship network of co-authors of Han Zhong Pei

This figure shows the co-authorship network connecting the top 25 collaborators of Han Zhong Pei. A scholar is included among the top collaborators of Han Zhong Pei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Han Zhong Pei. Han Zhong Pei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Pei, Han Zhong, Yuming Zhao, Zhiguang Chang, et al.. (2025). FLT3 inhibitors induce p53 instability, driven by STAT5/MDM2/p53 competitive interactions in acute myeloid leukemia. Cancer Letters. 611. 217446–217446. 3 indexed citations
2.
Pei, Han Zhong, Xiaomei Zhuang, Xiaobo Wang, et al.. (2023). miR-221/222 induce instability of p53 By downregulating deubiquitinase YOD1 in acute myeloid leukemia. Cell Death Discovery. 9(1). 249–249. 7 indexed citations
3.
Zhuang, Xiaomei, Han Zhong Pei, Tianwen Li, et al.. (2022). The Molecular Mechanisms of Resistance to IDH Inhibitors in Acute Myeloid Leukemia. Frontiers in Oncology. 12. 931462–931462. 24 indexed citations
4.
Zhao, Yuming, Han Zhong Pei, Ming Yang, et al.. (2021). Establishment of Stable Cell Lines Representing Juvenile Myelomonocytic Leukemia with SHP2 Mutations. Blood. 138(Supplement 1). 4353–4353. 1 indexed citations
5.
Pei, Han Zhong, Xiaomei Zhuang, Ming Yang, et al.. (2021). FLT3 Inhibitors Induce p53 Instability Due to Increased Interaction between p53 and MDM2 By Inhibiting STAT5 Phosphorylation in Acute Myeloid Leukemia. Blood. 138(Supplement 1). 3333–3333. 2 indexed citations
6.
Liu, Hongli, Dan Wang, Xin Li, et al.. (2020). Seven-Year Follow-up of Gene Therapy for Leber’s Hereditary Optic Neuropathy. Ophthalmology. 127(8). 1125–1127. 39 indexed citations
8.
Pei, Han Zhong, Bo Lü, Zhiguang Chang, et al.. (2020). FLT3 Inhibitors Induce Instability of p53 By Mir-181 Mediated Downregulation of Deubiquitinase YOD1 in Acute Myeloid Leukemia. Blood. 136(Supplement 1). 6–7. 4 indexed citations
9.
Pei, Han Zhong, Bin Huang, Hyeun‐Wook Chang, & Suk‐Hwan Baek. (2019). Ovarian tumor domain-containing ubiquitin aldehyde binding protein 1 inhibits inflammation by regulating Nur77 stability. Cellular Signalling. 59. 85–95. 14 indexed citations
10.
Huang, Bin, Han Zhong Pei, Hyeun‐Wook Chang, & Suk‐Hwan Baek. (2018). The E3 ubiquitin ligase Trim13 regulates Nur77 stability via casein kinase 2α. Scientific Reports. 8(1). 13895–13895. 26 indexed citations
11.
Pei, Han Zhong, et al.. (2017). Ovarian tumor domain-containing protein 1 deubiquitinates and stabilizes p53. Cellular Signalling. 33. 22–29. 51 indexed citations
12.
Wan, Xing, Han Zhong Pei, Shuo Yang, et al.. (2016). Efficacy and Safety of rAAV2-ND4 Treatment for Leber’s Hereditary Optic Neuropathy. Scientific Reports. 6(1). 21587–21587. 138 indexed citations
13.
Yang, Shuo, Siqi Ma, Xing Wan, et al.. (2016). Long-term outcomes of gene therapy for the treatment of Leber's hereditary optic neuropathy. EBioMedicine. 10. 258–268. 96 indexed citations
14.
Pei, Han Zhong, Xing Wan, Weikun Hu, Xiaoyan Dong, & Bin Li. (2013). Construction and detection of a novel type of recombinant human rAAV2/2-ND4.. PubMed. 28(2). 55–9. 11 indexed citations
15.
Shi, Hui, Jing Gao, Han Zhong Pei, et al.. (2012). Adeno‐associated virus‐mediated gene delivery of the human ND4 complex I subunit in rabbit eyes. Clinical and Experimental Ophthalmology. 40(9). 888–894. 15 indexed citations
16.
Hu, Weikun, et al.. (2011). Endoplasmic Reticulum Stress-Related Factors Protect against Diabetic Retinopathy. Experimental Diabetes Research. 2012. 1–8. 28 indexed citations
17.
Yang, Hong, Rong Liu, Zheng Cui, et al.. (2011). Functional characterization of 58-kilodalton inhibitor of protein kinase in protecting against diabetic retinopathy via the endoplasmic reticulum stress pathway.. PubMed. 17. 78–84. 28 indexed citations
18.
Yan, Shu, Zheng Cui, Zhiqi Chen, et al.. (2011). Expression of Endoplasmic Reticulum Stress-Related Factors in the Retinas of Diabetic Rats. Experimental Diabetes Research. 2012. 1–11. 19 indexed citations
19.
Pei, Han Zhong. (2002). Genetic Regulation of Organ Development and Programmed Cell Death. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026